Arkolith/Insider Trading/CINC/Form 4

Sofinnova Partners SAS

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Aug 17, 2022
Net Buying
Open-Market Buys
$4.0M
Open-Market Sells
$0
Net Open-Market Flow
$4.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2022Buy(P)133K$30.00$4.0M4.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-046250) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML